Published research is providing additional evidence of the effectiveness and safety of rapid-acting non-invasive brain stimulation therapy to treat people suffering from bipolar depression.
Read More
Testing a New Way to Precisely Target and Predict the Impact of TMS Brain Stimulation for Depression
As non-invasive brain stimulation—variations of TMS (transcranial magnetic stimulation)—continues to evolve and is administered to a growing number of patients with depression (and other illnesses,…
Read More
Depression that doesn’t respond to conventional treatments is a serious problem for all who are affected, and poses unique risks for those over 60. Late-life depression is often complicated by…
Read More
The two prevalent forms of non-invasive brain stimulation treatment for major depressive disorder have a well-documented ability to help patients, including some who have not been helped by popular…
Read More
On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach for major depressive disorder pioneered by Nolan Williams, M.D…
Read More
